{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:04:21Z","timestamp":1781813061985,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40119-025-00439-z","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:30:20Z","timestamp":1766064620000},"page":"43-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functionally Limiting Symptoms and Inability to Independently Complete Daily Activities Increase the Burden Felt by Caregivers to Patients with ATTR-CM"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1622-0732","authenticated-orcid":false,"given":"Francesco","family":"Cappelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ponti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Smorti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisith","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Burden of Disease Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"439_CR1","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:2872\u201391. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.003.","journal-title":"J Am Coll Cardiol"},{"key":"439_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","volume":"7","author":"RM Witteles","year":"2019","unstructured":"Witteles RM, Bokhari S, Damy T, et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice. JACC Heart Fail. 2019;7:709\u201316. https:\/\/doi.org\/10.1016\/j.jchf.2019.04.010.","journal-title":"JACC Heart Fail"},{"key":"439_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T, et al. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail. 2019;12:e006075. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006075.","journal-title":"Circ Heart Fail"},{"key":"439_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40120-018-0106-z","volume":"7","author":"M Stewart","year":"2018","unstructured":"Stewart M, Shaffer S, Murphy B, et al. Characterizing the high disease burden of transthyretin amyloidosis for patients and caregivers. Neurol Ther. 2018;7:349\u201364. https:\/\/doi.org\/10.1007\/s40120-018-0106-z.","journal-title":"Neurol Ther"},{"key":"439_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1238843","author":"L Ponti","year":"2023","unstructured":"Ponti L, Hsu K, Damy T, et al. Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study. Front Cardiovasc Med. 2023. https:\/\/doi.org\/10.3389\/fcvm.2023.1238843.","journal-title":"Front Cardiovasc Med"},{"key":"439_CR6","doi-asserted-by":"publisher","first-page":"595797","DOI":"10.3389\/fcvm.2025.1595797","volume":"12","author":"F Cappelli","year":"2025","unstructured":"Cappelli F, Ponti L, Hsu K, et al. Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey. Front Cardiovasc Med. 2025;12:595797. https:\/\/doi.org\/10.3389\/fcvm.2025.1595797.","journal-title":"Front Cardiovasc Med"},{"key":"439_CR7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1532-5415.2007.01307.x","volume":"55","author":"J Razani","year":"2007","unstructured":"Razani J, Kakos B, Orieta-Barbalace C, et al. Predicting caregiver burden from daily functional abilities of patients with mild dementia. J Am Geriatr Soc. 2007;55:1415\u201320. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01307.x.","journal-title":"J Am Geriatr Soc"},{"key":"439_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4306\/pi.2014.11.2.152","volume":"11","author":"HS Kang","year":"2014","unstructured":"Kang HS, Myung W, Na DL, et al. Factors associated with caregiver burden in patients with Alzheimer\u2019s disease. Psychiatry Investig. 2014;11:152\u20139. https:\/\/doi.org\/10.4306\/pi.2014.11.2.152.","journal-title":"Psychiatry Investig"},{"key":"439_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/10848223231214789","volume":"36","author":"S Hallinan","year":"2024","unstructured":"Hallinan S, Sobering J, Cardona-Martell I, et al. Care recipient factors that predict caregiver burden in older adult dyads. Home Health Care Manag Pract. 2024;36:191\u20136. https:\/\/doi.org\/10.1177\/10848223231214789.","journal-title":"Home Health Care Manag Pract"},{"key":"439_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ejcnurse.2010.03.001","volume":"9","author":"S Agren","year":"2010","unstructured":"Agren S, Evangelista L, Str\u00f6mberg A. Do partners of patients with chronic heart failure experience caregiver burden? Eur J Cardiovasc Nurs. 2010;9:254\u201362. https:\/\/doi.org\/10.1016\/j.ejcnurse.2010.03.001.","journal-title":"Eur J Cardiovasc Nurs"},{"key":"439_CR11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s40520-023-02419-6","volume":"35","author":"C Fumagalli","year":"2023","unstructured":"Fumagalli C, Smorti M, Ponti L, et al. Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis. Aging Clin Exp Res. 2023;35:1363\u20137. https:\/\/doi.org\/10.1007\/s40520-023-02419-6.","journal-title":"Aging Clin Exp Res"},{"key":"439_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.008105","volume":"14","author":"NM Fine","year":"2021","unstructured":"Fine NM, McMillan JM. Prevalence and prognostic significance of frailty among patients with transthyretin amyloidosis cardiomyopathy. Circ Heart Fail. 2021;14:e008105. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.008105.","journal-title":"Circ Heart Fail"},{"key":"439_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12247507","author":"S Cazalbou","year":"2023","unstructured":"Cazalbou S, Naccache L, Sourdet S, et al. Frailty in older patients with transthyretin cardiac amyloidosis. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12247507.","journal-title":"J Clin Med"},{"key":"439_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101123","volume":"3","author":"C Fumagalli","year":"2024","unstructured":"Fumagalli C, Maurer MS, Fontana M, et al. Comprehensive geriatric assessment to optimize the management of older patients with transthyretin cardiac amyloidosis. JACC Adv. 2024;3:101123. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101123.","journal-title":"JACC Adv"},{"key":"439_CR15","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.m146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146\u201356. https:\/\/doi.org\/10.1093\/gerona\/56.3.m146.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"439_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69\u201377. https:\/\/doi.org\/10.1016\/s0022-3999(01)00296-3.","journal-title":"J Psychosom Res"},{"key":"439_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12955-017-0759-9","volume":"15","author":"I Djukanovic","year":"2017","unstructured":"Djukanovic I, Carlsson J, \u00c5restedt K. Is the hospital anxiety and depression scale (HADS) a valid measure in a general population 65\u201380\u00a0years old? A psychometric evaluation study. Health Qual Life Outcomes. 2017;15:193. https:\/\/doi.org\/10.1186\/s12955-017-0759-9.","journal-title":"Health Qual Life Outcomes"},{"key":"439_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr.","year":"1996","unstructured":"Ware J Jr., Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"key":"439_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/s0895-4356(98)00109-7","volume":"51","author":"B Gandek","year":"1998","unstructured":"Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12\u00a0health survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171\u20138. https:\/\/doi.org\/10.1016\/s0895-4356(98)00109-7.","journal-title":"J Clin Epidemiol"},{"key":"439_CR20","unstructured":"Ware J, Kosinski M, Keller S. SF-12: how to score the SF-12 Physical and Mental Health Summary Scales. https:\/\/www.researchgate.net\/publication\/242636950_SF-12_How_to_Score_the_SF-12_Physical_and_Mental_Health_Summary_Scales. Accessed Aug 1, 2025."},{"key":"439_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1477-7525-8-143","volume":"8","author":"HH K\u00f6nig","year":"2010","unstructured":"K\u00f6nig HH, Heider D, Lehnert T, et al. Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual Life Outcomes. 2010;8:143. https:\/\/doi.org\/10.1186\/1477-7525-8-143.","journal-title":"Health Qual Life Outcomes"},{"key":"439_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11136-013-0553-z","volume":"23","author":"C Christodoulou","year":"2014","unstructured":"Christodoulou C, Schneider S, Junghaenel DU, Broderick JE, Stone AA. Measuring daily fatigue using a brief scale adapted from the Patient-Reported Outcomes Measurement Information System (PROMIS\u00ae). Qual Life Res. 2014;23:1245\u201353. https:\/\/doi.org\/10.1007\/s11136-013-0553-z.","journal-title":"Qual Life Res"},{"key":"439_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/26320843221089628","volume":"3","author":"CB Terwee","year":"2022","unstructured":"Terwee CB, Elsman EB, Roorda LD. DUPE towards standardization of fatigue measurement: psychometric properties and reference values of the PROMIS fatigue item bank in the Dutch general population. Res Methods Med Health Sci. 2022;3:86\u201398. https:\/\/doi.org\/10.1177\/26320843221089628.","journal-title":"Res Methods Med Health Sci"},{"key":"439_CR24","unstructured":"Zarit SH, Zarit JM, Pennsylvania State University Gerontology Center. The memory and behavior problems checklist and the burden interview. University Park, Pennsylvania State University, 1990."},{"key":"439_CR25","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1097\/jcn.0000000000000348","volume":"31","author":"SY Al-Rawashdeh","year":"2016","unstructured":"Al-Rawashdeh SY, Lennie TA, Chung ML. Psychometrics of the Zarit Burden Interview in caregivers of patients with heart failure. J Cardiovasc Nurs. 2016;31:E21\u20138. https:\/\/doi.org\/10.1097\/jcn.0000000000000348.","journal-title":"J Cardiovasc Nurs"},{"key":"439_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00127-005-0858-5","volume":"40","author":"RJ Williamson","year":"2005","unstructured":"Williamson RJ, Purcell S, Sterne A, et al. The relationship of fatigue to mental and physical health in a community sample. Soc Psychiatry Psychiatr Epidemiol. 2005;40:126\u201332. https:\/\/doi.org\/10.1007\/s00127-005-0858-5.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"439_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-021-01706-7","volume":"16","author":"D Rintell","year":"2021","unstructured":"Rintell D, Heath D, Braga Mendendez F, et al. Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups. Orphanet J Rare Dis. 2021;16:70. https:\/\/doi.org\/10.1186\/s13023-021-01706-7.","journal-title":"Orphanet J Rare Dis"},{"key":"439_CR28","doi-asserted-by":"publisher","first-page":"215013192211125","DOI":"10.1177\/21501319221112584","volume":"13","author":"W Suksatan","year":"2022","unstructured":"Suksatan W, Tankumpuan T, Davidson PM. Heart failure caregiver burden and outcomes: a systematic review. J Prim Care Community Health. 2022;13:21501319221112584. https:\/\/doi.org\/10.1177\/21501319221112584.","journal-title":"J Prim Care Community Health"},{"key":"439_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5498\/wjp.v6.i1.7","volume":"6","author":"N Sharma","year":"2016","unstructured":"Sharma N, Chakrabarti S, Grover S. Gender differences in caregiving among family\u2014caregivers of people with mental illnesses. World J Psychiatr. 2016;6:7\u201317. https:\/\/doi.org\/10.5498\/wjp.v6.i1.7.","journal-title":"World J Psychiatr"},{"key":"439_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/geronb\/gbx036","volume":"74","author":"J Swinkels","year":"2019","unstructured":"Swinkels J, Tilburg TV, Verbakel E, van Broese Groenou M. Explaining the gender gap in the caregiving burden of partner caregivers. J Gerontol B Psychol Sci Sol Sci. 2019;74:309\u201317. https:\/\/doi.org\/10.1093\/geronb\/gbx036.","journal-title":"J Gerontol B Psychol Sci Sol Sci"},{"key":"439_CR31","doi-asserted-by":"publisher","first-page":"P33","DOI":"10.1093\/geronb\/61.1.p33","volume":"61","author":"M Pinquart","year":"2006","unstructured":"Pinquart M, S\u00f6rensen S. Gender differences in caregiver stressors, social resources, and health: an updated meta-analysis. Gerontol B Psychol Sci Soc Sci. 2006;61:P33-45. https:\/\/doi.org\/10.1093\/geronb\/61.1.p33.","journal-title":"Gerontol B Psychol Sci Soc Sci"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00439-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-025-00439-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00439-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:26:26Z","timestamp":1773509186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-025-00439-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1007\/s40119-025-00439-z","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Francesco Cappelli reports honoraria for advisory board participation from Alnylam, Astra Zeneca, Bayer, BridgeBio, Novo Nordisk, and Pfizer; his institution has received an unconditional research grant from Pfizer. Martina Smorti reports speaker fees from Pfizer. Lucia Ponti and Kristen Hsu have no disclosures. Thibaud Damy has received consulting fees from Alnylam, GlaxoSmithKline, Pfizer, and Prothena; honoraria from Alnylam, Pfizer, and Prothena; research grants from GlaxoSmithKline and Pfizer; and clinical trial support from Alnylam, Ionis, and Pfizer. Nicolas Verheyen has received research grant, honoraria for advisory board participation, and speaker\u2019s fees from Pfizer. Ronnie Wang, Nisith Kumar, and Carmen Munteanu are employees of Pfizer and hold stock\/stock options.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Patients and caregivers provided informed consent to participate in the study. The study was approved by the institutional review board or independent ethics committee at each site. The study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}